A retrospective study to analyse the predictive factors for early mortality after initiation of regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer
Latest Information Update: 09 Jun 2019
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 09 Jun 2019 New trial record
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology